These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25066285)

  • 1. Methotrexate use and liver disease--a causal relationship?
    Schmitt J; Singh JA
    Br J Dermatol; 2014 Jul; 171(1):6-7. PubMed ID: 25066285
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate-induced liver cirrhosis in a patient of psoriasis.
    Avasthi G; Bhatt P; Singh J
    J Assoc Physicians India; 2012 May; 60():47-8. PubMed ID: 23029724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quest for an evidence-based approach to surveillance for methotrexate-related hepatotoxicity: promise and perils.
    Dawwas MF; Aithal GP
    Br J Dermatol; 2015 Jun; 172(6):1684-1685. PubMed ID: 25523838
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver biopsies and methotrexate: a time for reconsideration?
    Zachariae H
    J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
    Zachariae H
    Dermatology; 2005; 211(4):307-8. PubMed ID: 16286736
    [No Abstract]   [Full Text] [Related]  

  • 7. Psoriasis, transient elastography and methotrexate: monitoring at a tertiary hospital.
    Koch K
    Australas J Dermatol; 2021 Feb; 62(1):69-70. PubMed ID: 32700316
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate hepatotoxicity: what is the evidence?
    Ahern MJ; Smith MD; Roberts-Thomson PJ
    Inflamm Res; 1998 Apr; 47(4):148-51. PubMed ID: 9628257
    [No Abstract]   [Full Text] [Related]  

  • 9. Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications.
    van den Reek JMPA; Menting SP; Janssen WWL; Dhaliwal R; Heijboer AC; van Herwaarden AE; Sweep FCGJ; de Jong LM; Tjwa ET; Otero ME; Spuls PI; de Jong EMGJ
    Br J Dermatol; 2017 Nov; 177(5):1454-1457. PubMed ID: 28112796
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate for psoriasis in the era of biological therapy.
    Warren RB; Chalmers RJ; Griffiths CE; Menter A
    Clin Exp Dermatol; 2008 Aug; 33(5):551-4. PubMed ID: 18801095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current topics in psoriasis].
    Boulinguez S
    Ann Dermatol Venereol; 2011 Jun; 138(6 Suppl 1):H1-5. PubMed ID: 21703467
    [No Abstract]   [Full Text] [Related]  

  • 12. [Update on psoriasis at the Dermatology Day conference, Paris 2010].
    Battistella M; Boulinguez S
    Ann Dermatol Venereol; 2011 Apr; 138(2 Suppl 2):H1-10. PubMed ID: 21703456
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC; Cássia FF; Lamy F; Chagas VL; Ramos-e-Silva M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):25-9. PubMed ID: 18181969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy.
    Bray AP; Barnova I; Przemioslo R; Kennedy CT
    Br J Dermatol; 2012 May; 166(5):1125-7. PubMed ID: 21967341
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
    Aithal GP; Haugk B; Das S; Card T; Burt AD; Record CO
    Aliment Pharmacol Ther; 2004 Feb; 19(4):391-9. PubMed ID: 14871278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate.
    Campbell F; Laws P
    Br J Dermatol; 2024 Jul; 191(2):163. PubMed ID: 38504462
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?
    Kaffenberger BH; Kaffenberger JA; Wong H; Jarjour W; Levin D; Bechtel MA
    Int J Dermatol; 2015 Jul; 54(7):752-6. PubMed ID: 26108262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.
    Maybury CM; Samarasekera E; Douiri A; Barker JN; Smith CH
    Br J Dermatol; 2014 Jun; 170(6):1237-47. PubMed ID: 24588075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.
    Maybury CM; Jabbar-Lopez ZK; Wong T; Dhillon AP; Barker JN; Smith CH
    Br J Dermatol; 2014 Jul; 171(1):17-29. PubMed ID: 24606161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.